Abstract
A novel Zn mononuclear complex with 3-carboxy-pyrazole ligand has been prepared using conventional routes and characterized by X-ray diffraction. The structure consists of discrete neutral [Zn(C6H3N2O2)2(H2O)2] molecules held together by hydrogen interactions. This compound exhibits a potential in vivo antidiabetic activity and the in vitro toxicity can be considered negligible.
Keywords:
Antidiabetic activity; Coordination compound; in vitro toxicity.
© 2013.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Body Weight / drug effects
-
Diabetes Mellitus, Experimental / drug therapy
-
Eating / drug effects
-
Hypoglycemic Agents / chemical synthesis
-
Hypoglycemic Agents / chemistry*
-
Hypoglycemic Agents / pharmacology*
-
Male
-
Molecular Structure
-
Organometallic Compounds / chemical synthesis
-
Organometallic Compounds / chemistry*
-
Organometallic Compounds / pharmacokinetics*
-
Pyrazoles / chemistry
-
Rats
-
Rats, Wistar
-
X-Ray Diffraction
-
Zinc / chemistry*
Substances
-
Hypoglycemic Agents
-
Organometallic Compounds
-
Pyrazoles
-
pyrazole
-
Zinc